Dipotassium Oxalate for Postoperative Sensitivity in NCCLs
DIPOX-RCT
Comparative Evaluation of Dipotassium Oxalate in Postoperative Sensitivity Control in Class V Composite Restorations: A Randomized Controlled Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
Postoperative sensitivity is a common complication following Class V composite restorations, particularly in non-carious cervical lesions (NCCLs). This randomized controlled trial aims to evaluate the effectiveness of dipotassium oxalate as a pre-treatment agent in reducing postoperative sensitivity. A total of 64 participants will be randomly assigned into two groups: an intervention group receiving dipotassium oxalate prior to adhesive application, and a control group receiving standard adhesive protocol without pretreatment. Sensitivity will be assessed using a Visual Analog Scale (VAS) in response to cold and air stimuli at baseline, 24 hours, 7 days, and 30 days. The study aims to determine whether dipotassium oxalate significantly reduces postoperative sensitivity and can be incorporated into routine restorative dental practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 20, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
October 1, 2026
April 22, 2026
April 1, 2026
3 months
April 13, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Sensitivity
Measured using a 10-point Visual Analog Scale (VAS) after standardized air blast and cold stimulus. The minimum sensitivity score will be 1, while the maximum sensitivity score will be recorded 10.
24 hours, 7 days, and 30 days
Study Arms (2)
Dipotassium oxalate pretreatment before composite restoration
EXPERIMENTALParticipants receive dipotassium oxalate pretreatment before adhesive application and composite restoration.
No Dipotassium Oxalate Pre-treatment, Standard composite filling only
NO INTERVENTIONParticipants receive standard adhesive protocol without dipotassium oxalate pretreatment.
Interventions
Application of a 3% dipotassium oxalate gel to exposed dentin in non-carious cervical lesions prior to adhesive placement. The material is applied for 90 seconds and gently air-dried without rinsing, following manufacturer instructions. This pretreatment aims to occlude dentinal tubules through calcium oxalate crystal formation before restoration with a standard etch-and-rinse adhesive system and nanohybrid composite resin.
Eligibility Criteria
You may qualify if:
- Individuals aged 30 to 45 years.
- Presence of at least one tooth with a non-carious cervical lesion (Class V) with a lesion depth of ≥1 mm, requiring restorative treatment.
- The NCCL must show some symptoms/signs of pre-op sensitivity on applying stimulus (i.e Air burst / ethyl chloride spray) and will be recorded.
- The involved teeth must be vital and show no signs or symptoms of irreversible pulpitis or necrosis.
- Subjects must be willing to provide written informed consent and commit to the study's follow-up schedule.
- Subjects with fair to good oral hygiene as determined by a simplified oral hygiene index (OHI-S score ≤2).
You may not qualify if:
- Presence of carious lesions or restored teeth with existing secondary caries
- Any tooth with pulpal involvement, previous root canal therapy, or periapical pathology.
- Teeth with chronic periodontal disease( BPE score 3 and above.).
- Individuals regularly using Desensitizing toothpastes, NSAIDs, antidepressants, or any other pain-modulating drugs that may alter sensitivity reporting.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Punjab Dental Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 20, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04